Aug 26, 2025

Amansa Investments Limited on its acquisition of a minority stake in IP-led pharmaceutical company Rubicon Research Limited.

AZB & Partners acted for Amansa Investments Limited on its acquisition of a minority stake in IP-led pharmaceutical company Rubicon Research Limited by way of secondary sale by General Atlantic Singapore RR PTE Limited to Amansa, for purchase consideration of INR 250 crores.

Our deal team comprised our Senior Partner Vaidhyanadhan Iyer, Senior Associate Anshuman Bharadwaj, Associates Priya Venkatesan, Shraddha Sethia and Gaurav Jayakumar.

 

AUTHORS & CONTRIBUTORS

  • Partner:

    Vaidhyanadhan Iyer

  • Associates:

    Anshuman Bharadwaj

    Priya Venkatesan

    Shraddha Sethia

    Gaurav Jayakumar

TAGS

SHARE

DISCLAIMER

These are the views and opinions of the author(s) and do not necessarily reflect the views of the Firm. This article is intended for general information only and does not constitute legal or other advice and you acknowledge that there is no relationship (implied, legal or fiduciary) between you and the author/AZB. AZB does not claim that the article's content or information is accurate, correct or complete, and disclaims all liability for any loss or damage caused through error or omission.